knowledge
Previous article:
DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article: The biotech scorecard for Q1: 17 stock
Next article: The biotech scorecard for Q1: 17 stock
focus
focus
-
The FDA must approve intranasal treatments for anaphylaxis
2025-09-29 22:42 -
J&J to buy cancer drug developer Ambrx Biopharma
2025-09-29 21:25 -
Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi
2025-09-29 21:15 -
STAT Readout Newsletter: Today in biotech, life science news
2025-09-29 20:35 -
Ahead of JPM, here's who's profiting most in health care
2025-09-29 20:26 -
Readout LOUD podcast: Merger Mondays, Ozempic panic
2025-09-29 20:21